Pages that link to "Q37660489"

The following pages link to Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy (Q37660489):

Displaying 43 items.

• Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis (Q26765777) (← links)
• Structural basis of kynurenine 3-monooxygenase inhibition (Q27677296) (← links)
• Effects of various phytochemicals on indoleamine 2,3-dioxygenase 1 activity: galanal is a novel, competitive inhibitor of the enzyme (Q28539745) (← links)
• Metabolomic Analyses of Leishmania Reveal Multiple Species Differences and Large Differences in Amino Acid Metabolism (Q28548008) (← links)
• Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors (Q28818166) (← links)
• The implications of relationships between human diseases and metabolic subpathways (Q33939198) (← links)
• Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors (Q34336127) (← links)
• IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation (Q34396547) (← links)
• Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer (Q34414152) (← links)
• Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase (Q34427452) (← links)
• Trial Watch: Peptide-based anticancer vaccines (Q34483345) (← links)
• Indoleamine 2,3-Dioxygenase Mediates the Antiviral Effect of Gamma Interferon against Hepatitis B Virus in Human Hepatocyte-Derived Cells (Q34485130) (← links)
• Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer (Q35221827) (← links)
• Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma (Q35775787) (← links)
• Complete reaction mechanism of indoleamine 2,3-dioxygenase as revealed by QM/MM simulations. (Q35832639) (← links)
• Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies (Q36236730) (← links)
• Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma (Q36747510) (← links)
• Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. (Q36814160) (← links)
• New Cyclic Lipopeptides of the Iturin Class Produced by Saltern-Derived Bacillus sp. KCB14S006. (Q36847354) (← links)
• The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1 (Q37146296) (← links)
• Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer (Q37798692) (← links)
• Improving cancer immunotherapy by targeting tumor-induced immune suppression (Q37830362) (← links)
• Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy (Q37983730) (← links)
• INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology (Q38775788) (← links)
• Immunomodulating effect of ethyl pyruvate on nonsyngenic transplanted tumor in mice (Q39052137) (← links)
• Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma (Q39514618) (← links)
• Pharmacokinetics of 1-methyl-L-tryptophan after single and repeated subcutaneous application in a porcine model. (Q40150132) (← links)
• Indoleamine 2,3-dioxygenase 1 in corneal endothelial cells limits herpes simplex virus type 1-induced acquired immune response (Q41123380) (← links)
• Evaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging (Q41470807) (← links)
• Synthesis of [(18) F] 4-amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide (IDO5L): a novel potential PET probe for imaging of IDO1 expression (Q41814909) (← links)
• Indoleamine 2,3-dioxygenase inhibitors: potential treatment for cancer, sepsis, and more (Q41951914) (← links)
• Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells (Q43083243) (← links)
• Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity (Q45865862) (← links)
• Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells (Q46182219) (← links)
• Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions (Q49328492) (← links)
• Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis (Q50025803) (← links)
• Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism (Q51030756) (← links)
• Overexpression of indoleamine 2, 3-dioxygenase contributes to the repair of human airway epithelial cells inhibited by dexamethasone via affecting the MAPK/ERK signaling pathway. (Q55022569) (← links)
• Possible Mechanisms of Green Tea and Its Constituents against Cancer (Q58691575) (← links)
• Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation (Q60922161) (← links)
• Control of the Antitumor Immune Response by Cancer Metabolism (Q64243032) (← links)
• The Immunomodulator 1-Methyltryptophan Drives Tryptophan Catabolism Toward the Kynurenic Acid Branch (Q90379873) (← links)
• Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment (Q92650579) (← links)